StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) SEC filings

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.36+0.22 (+1.15%)

Close on Nov 16, 2026Market cap $930.41MP/E –Yield –

SEC filings

10 of Odyssey Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 4, 2026SEC EDGAR
Current report8-KNov 4, 2026Nov 4, 2026SEC EDGAR
Current report8-KOct 20, 2026Oct 20, 2026SEC EDGAR
Current report8-KSep 8, 2026Sep 9, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 6, 2026SEC EDGAR
Current report8-KAug 4, 2026Aug 4, 2026SEC EDGAR
Current report8-KJun 23, 2026Jun 23, 2026SEC EDGAR
Current report8-KJun 17, 2026Jun 17, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026Jun 17, 2026SEC EDGAR
Current report8-KMay 7, 2026May 11, 2026SEC EDGAR

See a number that looks wrong?